Purification and Proliferation of Human Myoblasts Isolated with Fluorescence Activated Cell Sorting

  • Helen M. Blau
  • Cecelia Webster
  • Grace K. Pavlath
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 280)


Myoblast therapy, or the transfer of normal myoblasts into dystrophic muscle, requires both a large number and high purity of human myoblasts. Solutions to both of these problems are presented below.


Satellite Cell Proliferative Capacity Duchenne Muscular Dystrophy Duchenne Muscular Dystrophy Patient Human Myoblast 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hauschka, S.D., Clonal analysis of vertebrate myogenesis II. Environmental influences upon human muscle differentiation, Dev. Biol. 37:329 (1974).Google Scholar
  2. 2.
    Hauschka, S.D., Clonal analysis of vertebrate myogenesis. 3. Developmental changes in the muscle-colony-forming cells of the human fetal limb, Dev. Biol. 37:345 (1974).Google Scholar
  3. 3.
    Blau, H.M. and C. Webster, Isolation and characterization of human muscle cells, Proc. Natl. Acad. Sci. USA 78: 5623 (1981).PubMedCrossRefGoogle Scholar
  4. 4.
    Blau, H.M., I. Kaplan, T.-W. Tao and J.P. Kriss, Thyroglobulin-independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves’ ophthalmopathy, Life Sci. 32: 45 (1982).Google Scholar
  5. 5.
    Blau, H.M., C. Webster, C.-P. Chiu, S. Guttman and F. Chandler, Differentiation properties of pure populations of human dystrophic muscle cells, Exp. Cell Res. 744:495 (1983).Google Scholar
  6. 6.
    Blau, H.M., C. Webster and G.K. Pavlath, Defective myoblasts identified in Duchenne muscular dystrophy, Proc. Natl. Acad. Sci. USA 80:4856 (1983).Google Scholar
  7. 7.
    Blau, H.M., G.K. Pavlath, E.C. Hardeman, C.-P. Chiu, L. Silberstein, S.G. Webster, S.C. Miller and C. Webster, Plasticity of the differentiated state, Science 230: 758 (1985).Google Scholar
  8. 8.
    Costa, E.M., H.M. Blau and D. Feldman, 1,25 dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells, Endocrin. 119: 2214 (1986).Google Scholar
  9. 9.
    Hardeman, E., C.-P. Chiu, A. Minty and H.M. Blau, The pattern of actin expression in human fibroblast X mouse muscle heterokaryons suggests that human muscle regulatory factors are produced, Cell, 47: 123 (1986).PubMedCrossRefGoogle Scholar
  10. 10.
    Kaplan, I.K. and H.M. Blau, Metabolic properties of human acetylcholine receptors can be characterized on cultured human muscle, Exp. Cell Res. 166:379 (1986).Google Scholar
  11. 11.
    Shimizu, M., C. Webster, D.O. Morgan, H.M. Blau and R.A. Roth, Insulin and insulin-like growth factor receptors and responses in cultured human muscle cells, Amer. J. Phvsiol. 251:E611 (1986).Google Scholar
  12. 12.
    Webster, C., G. Filippi, A. Rinaldi, C. Mastopaolo, M. Tondi, M. Siniscalco, and H.M. Blau, The myoblast defect identified in Duchenne muscular dystrophy is not a primary expression of the DMD mutation: Clonal analysis of myoblasts from double heterozygotes for two X-linked loci: DMD and G6PD, Human Genetics 74: 74 (1986).Google Scholar
  13. 13.
    Gunning, P., E. Hardeman, R. Wade, P. Ponte, W. Bains, H.M. Blau and L. Kedes, Differential patterns of transcript accumulation during human myogenesis, Mol. Cell Biol., 7:4100 (1987).Google Scholar
  14. 14.
    Miller, S.C., H.Ito, H.M. Blau and F.M. Torti, Tumor necrosis factor inhibits human myogenesis in vitro, Mol. Cell Biol. 8: 2295 (1988).Google Scholar
  15. 15.
    Webster, C., G.K. Pavlath, F.S. Walsh and H.M. Blau, Isolation of human myoblasts with the fluorescence-activated cell sorter, Exp. Cell Res. 174:25 (1988).Google Scholar
  16. 16.
    Webster, C. and H.M. Blau, Extensive proliferative capacity of normal postnatal human myoblasts, 1989 submitted.Google Scholar
  17. 17.
    Yasin, R., F.S. Walsh, D.N. Landon and E.J. Thompson, New approaches to the study of human dystrophic muscle cells in culture, J. Neurol. Sci. 58:315 (1983).Google Scholar
  18. 18.
    Miranda, A.F., T. Mongini, and S. DiMauro, Human myopathies in muscle culture: Morphological, cytochemical, and biochemical studies, Adv. Cell Culture. 4:1 (1985).Google Scholar
  19. 19.
    Martinuzzi, A., V. Askanas, T. Kobayashi, W.K. Engel and S. DiMauro, Expression of muscle-gene-specific isozymes of phosphorylase and creatine kinase in innervated cultured human muscle, J. Cell Biol. 103:1423 (1986).Google Scholar
  20. 20.
    Ham, R.G., J.A. St.Clair, C. Webster and H.M. Blau, Improved media for normal human muscle satellite cells: serum-free clonal growth with low serum, In Vitro Cell. Dev. Biol. 24:833 (1988).Google Scholar
  21. 21.
    Hurko, O., E.P. Hoffman, L. McKee, D.R. Johns and L.M. Kunkel, Dystrophin analysis in clonal myoblasts derived from a Duchenne muscular dystrophy carrier, Amer. J. Hum. Genet. 44:820 (1989).Google Scholar
  22. 22.
    Walsh, F.S., G. Dickson, S. Moore and C.H. Barton, Unmasking N-CAM, Nature 339: 516 (1989).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Helen M. Blau
    • 1
  • Cecelia Webster
    • 1
  • Grace K. Pavlath
    • 1
  1. 1.Department of PharmacologyStanford University School of MedicineStanfordUSA

Personalised recommendations